Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells

J Biol Chem. 2002 Mar 8;277(10):8724-9. doi: 10.1074/jbc.M110594200. Epub 2001 Dec 20.

Abstract

Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) has been recently identified as a mitogen specific for the endothelium of steroidogenic glands. Here we report a characterization of the signal transduction of EG-VEGF in a responsive cell type, bovine adrenal cortex-derived endothelial (ACE) cells. EG-VEGF led to a time- and dose-dependent phosphorylation of p44/42 MAPK. This effect was blocked by pretreatment with pertussis toxin, suggesting that G alpha(i) plays an important role in mediating EG-VEGF-induced activation of MAPK signaling. The inhibitor of p44/42 MAPK phosphorylation PD 98059 resulted in suppression of both proliferation and migration in response to EG-VEGF. EG-VEGF also increased the phosphorylation of Akt in a phosphatidylinositol 3-kinase-dependent manner. Consistent with such an effect, EG-VEGF was a potent survival factor for ACE cells. We also identified endothelial nitric-oxide synthase as one of the downstream targets of Akt activation. Phosphorylation of endothelial nitric-oxide synthase in ACE cells was stimulated by EG-VEGF with a time course correlated to the Akt phosphorylation. Our data demonstrate that EG-VEGF, possibly through binding to a G-protein coupled receptor, results in the activation of MAPK p44/42 and phosphatidylinositol 3-kinase signaling pathways, leading to proliferation, migration, and survival of responsive endothelial cells.

MeSH terms

  • Adrenal Cortex / blood supply*
  • Adrenal Cortex / metabolism
  • Animals
  • Blotting, Western
  • Cattle
  • Cell Division
  • Cell Movement
  • Cell Survival
  • Dose-Response Relationship, Drug
  • Endocrine Glands / metabolism*
  • Endothelial Growth Factors / metabolism*
  • Endothelium, Vascular / cytology*
  • Endothelium, Vascular / metabolism
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Lymphokines / metabolism*
  • MAP Kinase Signaling System
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases / metabolism
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type III
  • Pertussis Toxin
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphorylation
  • Precipitin Tests
  • Signal Transduction*
  • Time Factors
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Virulence Factors, Bordetella / pharmacology

Substances

  • Endothelial Growth Factors
  • Enzyme Inhibitors
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Virulence Factors, Bordetella
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Pertussis Toxin
  • Phosphatidylinositol 3-Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases